Does point of care prothrombin time measurement reduce the transfusion of fresh frozen plasma in patients undergoing major surgery? The POC-OP randomized-controlled trial

Trials

Volumn 10, Issue , 2009, Pages

  Urwyler, Natalie ^a   Trelle, Sven ^a   Theiler, Lorenz ^a   Jüni, Peter ^a   Staub, Lukas P ^b   Luyet, Cedric ^a   Alberio, Lorenzo ^a   Stricker, Kay ^a   Greif, Robert ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BLOOD VOLUME; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMORRHAGIC SHOCK; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POINT OF CARE TESTING; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SEPSIS; SURGICAL INFECTION; SURGICAL RISK; SURGICAL TECHNIQUE; ADOLESCENT; HOSPITAL INFORMATION SYSTEM; METHODOLOGY; MIDDLE AGED; PLASMA; SAMPLE SIZE; SURGERY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PLASMA; POINT-OF-CARE SYSTEMS; PROTHROMBIN TIME; RESEARCH DESIGN; SAMPLE SIZE; SURGICAL PROCEDURES, OPERATIVE;

EID: 71549163456     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-10-107     Document Type: Article

References (40)

1. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006, 105:198-208. 10.1097/00000542-200607000-00030, 16810012.
2. Jones J. Abuse of fresh frozen plasma. Br Med J (Clin Res Ed) 1987, 295:287. 10.1136/bmj.295.6593.287, 1247136, 3115415.
3. MacLennan S, Williamson LM. Risks of fresh frozen plasma and platelets. J Trauma 2006, 60:S46-50.
4. Norda R, Tynell E, Akerblom O. Cumulative risks of early fresh frozen plasma, cryoprecipitate and platelet transfusion in Europe. J Trauma 2006, 60:S41-45. 10.1097/01.ta.0000199546.22925.31, 16763480.
5. Brander L, Reil A, Bux J, Taleghani BM, Regli B, Takala J. Severe transfusion-related acute lung injury. Anesth Analg 2005, 101:499-501. table of contents, 10.1213/01.ANE.0000159375.26910.9C, 16037167.
6. Stroncek DF, Rebulla P. Platelet transfusions. Lancet 2007, 370:427-438. 10.1016/S0140-6736(07)61198-2, 17679020.
7. Edgren G, Hjalgrim H, Reilly M, Tran TN, Rostgaard K, Shanwell A, Titlestad K, Adami J, Wikman A, Jersild C, Gridley G, Wideroff L, Nyrén O, Melbye M. Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet 2007, 369:1724-1730. 10.1016/S0140-6736(07)60779-X, 17512857.
8. Marik PE, Corwin HL. Acute lung injury following blood transfusion: expanding the definition. Crit Care Med 2008, 36:3080-3084. 10.1097/CCM.0b013e31818c3801, 18824899.
9. Jia X, Malhotra A, Saeed M, Mark RG, Talmor D. Risk factors for ARDS in patients receiving mechanical ventilation for > 48 h. Chest 2008, 133:853-861. 10.1378/chest.07-1121, 2628459, 18263691.
10. Ruhl H, Bein G, Sachs UJ. Transfusion-associated graft-versus-host disease. Transfus Med Rev 2009, 23:62-71. 10.1016/j.tmrv.2008.09.006, 19056035.
11. Spence RK. Surgical red blood cell transfusion practice policies. Blood Management Practice Guidelines Conference. Am J Surg 1995, 170:3S-15S. 10.1016/S0002-9610(99)80052-X, 8546244.
12. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996, 84:732-747. 10.1097/00000542-199603000-00032, 8659805.
13. Spahn DR, Moch H, Hofmann A, Isbister JP. Patient blood management: the pragmatic solution for the problems with blood transfusions. Anesthesiology 2008, 109:951-953. 10.1097/ALN.0b013e31818e3d75, 19034088.
14. Kawai A, Kadota H, Yamaguchi U, Morimoto Y, Ozaki T, Beppu Y. Blood loss and transfusion associated with musculoskeletal tumor surgery. J Surg Oncol 2005, 92:52-58. 10.1002/jso.20375, 16180233.
15. Gottfried ON, Schmidt MH, Stevens EA. Embolization of sacral tumors. Neurosurg Focus 2003, 15:E4. 10.3171/foc.2003.15.2.4, 15350035.
16. Owen RJ. Embolization of musculoskeletal tumors. Radiol Clin North Am 2008, 46:535-543. vi, 10.1016/j.rcl.2008.02.002, 18707961.
17. Lier H, Krep H, Schroeder S, Stuber F. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 2008, 65:951-960. 10.1097/TA.0b013e318187e15b, 18849817.
18. Toulon P, Ozier Y, Ankri A, Fleron MH, Leroux G, Samama CM. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 2009, 101:394-401.
19. Ketchum L, Hess JR, Hiippala S. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma 2006, 60:S51-58. 10.1097/01.ta.0000199432.88847.0c, 16763482.
20. Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiol 2007, 73:401-415.
21. Poller L, Keown M, Ibrahim SA, Meer FJ, Besselaar AM, Tripodi A, Jespersen J, Meijer P, Kluft C. Quality assessment of CoaguChek point-of-care prothrombin time monitors: comparison of the European community-approved procedure and conventional external quality assessment. Clin Chem 2006, 52:1843-1847. 10.1373/clinchem.2006.071639, 16998117.
22. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008, 106:1366-1375. 10.1213/ane.0b013e318168b367, 18420846.
23. Gorlinger K. [Coagulation management during liver transplantation]. Hamostaseologie 2006, 26:S64-76.
24. Straub A, Schiebold D, Wendel HP, Hamilton C, Wagner T, Schmid E, Dietz K, Ziemer G. Using reagent-supported thromboelastometry (ROTEM) to monitor haemostatic changes in congenital heart surgery employing deep hypothermic circulatory arrest. Eur J Cardiothorac Surg 2008, 34:641-647. 10.1016/j.ejcts.2008.05.028, 18579398.
25. Nuttall GA, Oliver WC, Santrach PJ, Bryant S, Dearani JA, Schaff HV, Ereth MH. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001, 94:773-781. discussion 775A-776A, 10.1097/00000542-200105000-00014, 11388527.
26. Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Cox JL, Barnes P, Lappas DG. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1994, 107:271-279.
27. Wong J, El Beheiry H, Rampersaud YR, Lewis S, Ahn H, De Silva Y, Abrishami A, Baig N, McBroom RJ, Chung F. Tranexamic Acid reduces perioperative blood loss in adult patients having spinal fusion surgery. Anesth Analg 2008, 107:1479-1486. 10.1213/ane.0b013e3181831e44, 18931202.
28. Moore FA, Nelson T, McKinley BA, Moore EE, Nathens AB, Rhee P, Puyana JC, Beilman GJ, Cohn SM. Is there a role for aggressive use of fresh frozen plasma in massive transfusion of civilian trauma patients?. Am J Surg 2008, 196:948-958. discussion 958-960, 10.1016/j.amjsurg.2008.07.043, 19095115.
29. Bossuyt PM, Lijmer JG, Mol BW. Randomised comparisons of medical tests: sometimes invalid, not always efficient. Lancet 2000, 356:1844-1847. 10.1016/S0140-6736(00)03246-3, 11117930.
30. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, Yancy CW. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007, 116:e418-499. 10.1161/CIRCULATIONAHA.107.185699, 17901357.
31. Plesch W, Klimpel P. Performance evaluation of the CoaguChek S system. Haematologica 2002, 87:557-559.
32. Stravitz RT. Critical management decisions in patients with acute liver failure. Chest 2008, 134:1092-1102. 10.1378/chest.08-1071, 18988787.
33. Gibbs NM. The effect of anaesthetic agents on platelet function. Anaesth Intensive Care 1991, 19:495-505.
34. Niccolai I, Barontini L, Paolini P, Lavacchi L, Bracciotti G, Pellegrini F, Aiardi F, Ferlito A. [Long-term sedation with propofol in ICU: hemocoagulation problems]. Minerva Anestesiol 1992, 58:375-379.
35. Inselspital. , http://www.hzl.insel.ch/1145.html
36. Urwyler N, Staub LP, Beran D, Deplazes M, Lord SJ, Alberio L, Theiler L, Greif R. Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test?. Thromb Haemost 2009, 102:779-786.
37. Taborski U, Braun SL, Voller H. Analytical performance of the new coagulation monitoring system INRatio for the determination of INR compared with the coagulation monitor Coaguchek S and an established laboratory method. J Thromb Thrombolysis 2004, 18:103-107. 10.1007/s11239-004-0206-8, 15789176.
38. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994, 308:81-106. 2539220, 8298418.
39. Harel O, Zhou XH. Multiple imputation: review of theory, implementation and software. Stat Med 2007, 26:3057-3077. 10.1002/sim.2787, 17256804.
40. Brookes ST, Whitely E, Egger M, Smith GD, Mulheran PA, Peters TJ. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol 2004, 57:229-236. 10.1016/j.jclinepi.2003.08.009, 15066682.